Pacifica, CA, United States of America

Gary Elliott

This inventor holds 1 USPTO granted patent. Top assignee: Allergy Therapeutics (UK) Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Elliott. Retrieved from https://idiyas.com/inventor/gary-elliott-518uyexr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Gary Elliott

Introduction

Gary Elliott is an accomplished inventor based in Pacifica, California. He has made significant contributions to the field of immunology through his innovative work. With a focus on enhancing immune responses, Elliott has developed a unique method that has the potential to impact medical treatments.

Latest Patents

Elliott holds a patent for a composition of antigen and glycolipid adjuvant for sublingual administration. This patent describes a method of producing a mucosal and systemic immune response in a mammal. The process involves administering an effective amount of a composition that includes at least one antigen and a glycolipid adjuvant sublingually to the mammal. This innovative approach could lead to advancements in vaccine delivery and immune response enhancement.

Career Highlights

Elliott is currently associated with Allergy Therapeutics (UK) Limited, where he continues to work on groundbreaking research in immunology. His career is marked by a commitment to developing effective treatments that can improve patient outcomes.

Collaborations

Elliott has collaborated with notable colleagues, including Alan Worland Wheeler and Christopher W. Cluff. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Gary Elliott's contributions to the field of immunology through his patent and work at Allergy Therapeutics (UK) Limited highlight his dedication to advancing medical science. His innovative methods have the potential to significantly enhance immune responses, paving the way for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…